Skip to main content

Table 3 Accordance of the package sizes of selected drugs with guidelines for urinary tract infections I

From: Evaluation of accordance of antibiotics package size with recommended treatment duration of guidelines for sore throat and urinary tract infections

Drug

Package size

ISKRAa

Min No. of packages

Extra units

IDSAb

Co-amoxiclav

10x1000 mg

2x1000 mg, 7 days

2

6

n/a

2x1000 mg, 10-14 days

2 (10 days)

0

2x1000 mg, 14 days

3

2

2x1000 mg, 28 days

6

4

12x1000mgc

2x1000 mg, 7 days

2

10

2x1000 mg, 10-14 days

2 (12 days)

0

2x1000 mg, 14 days

3

8

2x1000 mg, 28 days

5

4

14x1000 mgc

2x1000 mg, 7 days

1

0

2x1000 mg, 10-14 days

2 (14 days)

0

2x1000 mg, 14 days

2

0

2x1000 mg, 28 days

4

0

16x1000 mg

2x1000 mg, 7 days

1

2

2x1000 mg, 10-14 days

2 (14 days)

4

2x1000 mg, 14 days

2

4

2x1000 mg, 28 days

4

8

20x1000 mg

2x1000 mg, 7 days

1

6

2x1000 mg, 10-14 days

1 (10 days)

0

2x1000 mg, 14 days

2

12

2x1000 mg, 28 days

3

4

21x1000 mg

2x1000 mg, 7 days

1

7

2x1000 mg, 10-14 days

1 (10 days)

1

2x1000 mg, 14 days

2

14

2x1000 mg, 28 days

3

7

24x1000 mg

2x1000 mg, 7 days

1

10

2x1000 mg, 10-14 days

1 (12 days)

0

2x1000 mg, 14 days

2

20

2x1000 mg, 28 days

3

16

30x1000 mg

2x1000 mg, 7 days

1

16

2x1000 mg, 10-14 days

1 (14 days)

2

2x1000 mg, 14 days

1

2

2x1000 mg, 28 days

2

4

Cephalexin

16x500 mgc

2x1000 mg, 7 days

2

4

n/a

16x1000 mgc

2x1000 mg, 7 days

1

2

Cefixime

5x400 mgc

1x400 mg, 10-14 days

2 (10 days)

0

n/a

1x400 mg, 14 days

3

1

1x400 mg, 28 days

6

2

10x400 mgc

1x400 mg, 10-14 days

1 (10 days)

0

1x400 mg, 14 days

2

6

1x400 mg, 28 days

3

2

Cefuroxime

10x125 mgc

2x500 mg, 10-14 days

8 (10 days)

0

n/a

2x500 mg, 14 days

12

8

2x500 mg, 28 days

23

6

10x250 mgc

2x500 mg, 10-14 days

4 (10 days)

0

2x500 mg, 14 days

6

4

2x500 mg, 28 days

12

8

8x500 mg

2x500 mg, 10-14 days

3 (12 days)

0

2x500 mg, 14 days

4

4

2x500 mg, 28 days

7

0

10x500 mgc

2x500 mg, 10-14 days

2 (10 days)

0

2x500 mg, 14 days

3

2

2x500 mg, 28 days

6

4

12x500 mg

2x500 mg, 10-14 days

2 (12 days)

0

2x500 mg, 14 days

3

8

2x500 mg, 28 days

5

4

14x500 mgc

2x500 mg, 10-14 days

2 (14 days)

0

2x500 mg, 14 days

2

0

2x500 mg, 28 days

4

0

15x500 mg

2x500 mg, 10-14 days

2 (14 days)

2

2x500 mg, 14 days

2

2

2x500 mg, 28 days

4

4

16x500 mgc

2x500 mg, 10-14 days

2 (14 days)

4

2x500 mg, 14 days

2

4

2x500 mg, 28 days

4

8

20x500 mg

2x500 mg, 10-14 days

1 (10 days)

0

2x500 mg, 14 days

2

12

2x500 mg, 28 days

3

4

24x500 mg

2x500 mg, 10-14 days

1 (12 days)

0

2x500 mg, 14 days

2

20

2x500 mg, 28 days

3

16

Norfloxacin

20x400 mgc

2x400 mg, 3 days

1

14

n/a

  1. Co-amoxiclav – amoxicillin and clavulanic acid; n/a – not applicable; extra units of drugs are presented with reference to the original formulation
  2. aThe Intersectoral Society for Antibiotic Resistance Control (ISKRA) guidelines on antimicrobial treatment and prophylaxis of urinary tract infections
  3. bInternational Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
  4. cincluded in Croatian national reimbursement lists on 1st August 2018